SOUTH SAN FRANCISCO, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) — VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new […]
First commercially available, automated single-cell analysis application to enable co-detection of cellular protein and RNA expression using microfluidics technology SOUTH […]